American Portfolios Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
American Portfolios Advisors's DGX Position: Q3 2022 in Review
American Portfolios Advisors reduced its Quest Diagnostics (DGX) stake by 3.4% in Q3 2022, selling an estimated $3.42K and leaving 740 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.
American Portfolios Advisors first reported a position in DGX in Q1 2018 and has held it in 17 quarters since. The position peaked at $128K in Q1 2022. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- American Portfolios Advisors held 740 shares of Quest Diagnostics worth $90.8K as of Q3 2022.
- American Portfolios Advisors sold 26 Quest Diagnostics shares in Q3 2022, an estimated $3.42K.
- Quest Diagnostics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1409 holding.
- American Portfolios Advisors first reported a position in Quest Diagnostics in Q1 2018 and has held it in 17 quarters since.
- American Portfolios Advisors's Quest Diagnostics position peaked at $128K in Q1 2022.
- 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.